We have located links that may give you full text access.
Journal Article
Review
ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zinc finger protein 384 ( ZNF384 ) encodes a C2H2-type zinc finger protein that can function as a transcription factor. ZNF384 rearrangement in acute lymphoblastic leukemia (ALL) was first reported in 2002. More than 19 different ZNF384 fusion partners have been detected in ALL. These include E1A-binding protein P300 ( EP300 ), CREB-binding protein ( CREBBP ), transcription factor 3 ( TCF3 ), TATA-box binding protein associated factor 15 ( TAF15 ), Ewing sarcoma breakpoint region 1 gene ( EWSR1 ), AT-rich interactive domain-containing protein 1B ( ARID1B ), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4 ( SMARCA4 ), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 2 ( SMARCA2 ), synergin gamma ( SYNRG ), clathrin heavy chain ( CLTC ), bone morphogenic protein 2-inducible kinase ( BMP2K ), Nipped-B-like protein ( NIPBL ), A Kinase Anchoring Protein 8 ( AKAP8 ), Chromosome 11 Open Reading Frame 74 ( C11orf74 ), DEAD-Box Helicase 42 ( DDX42 ), ATP Synthase F1 Subunit Gamma ( ATP2C1 ), Euchromatic Histone Lysine Methyltransferase 1 ( EHMT1 ), Testic Expressed 41 ( TEX41 ), etc. Patients diagnosed with ALL harboring ZNF384 rearrangements commonly had a good prognosis. The mechanisms, performance, and features of different ZNF384 rearrangements in acute lymphoblastic leukemia have been well evaluated.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app